undefined
EUTM file information

011232725

PHARMIDA


October 1, 2012

Trademark Summary

The trademark PHARMIDA was filed by Midatech Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on November 29, 2012, and received one opposition filed on February 26, 2013 by Sandoz Limited on Likelihood of confusion. the opponent was represented by FRIEDRICH GRAF VON WESTPHALEN & PARTNER MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued February 26, 2013

The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).

The renewal of the trademark was recorded by the office on August 2, 2023.

of the trademark registration was recorded on August 2, 2023. Change of name and professional address of the trademark registration was recorded on May 11, 2015. Change of name and address of the trademark registration was recorded on August 26, 2015. Change of name and address of the trademark registration was recorded on September 6, 2015. Change of name and address of the trademark registration was recorded on February 5, 2019. Change of name and address of the trademark registration was recorded on February 27, 2020. Change of name and professional address of the trademark registration was recorded on December 15, 2020. Appointment and Replacement of representative of the trademark registration was recorded on January 6, 2021.


Goods And Services

  • The mark was filed in class 1 with Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines and nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics..
  • The mark was filed in class 42 with following description of goods:
    1. Scientific research services in the field of nano-particle technology
    2. Pharmaceutical and drug development and discovery services
    3. Testing, efficiency and advisory services in the field of nano-particles, pharmaceuticals and nano-medicine
    4. Nano-particle laboratory services.